Effect Sizes and Confidence Intervals

  • Effect sizes and confidence intervals are fundamental statistical concepts in bioinformatics because they help researchers understand the magnitude, direction, and precision of observed biological associations. Statistical significance alone does not indicate whether an association is biologically meaningful. A very small effect may produce a low p-value in a large dataset, while a potentially important effect may fail to reach statistical significance in a small or underpowered study. Effect sizes describe how large an observed difference, association, or relationship is, whereas confidence intervals communicate the uncertainty surrounding an estimated effect. Together, they provide a more informative interpretation of results from genome-wide association studies (GWAS), differential gene expression analysis, transcriptomics, proteomics, metabolomics, clinical genomics, and other biological investigations.
  • An effect size is a numerical measure of the magnitude and direction of a relationship or difference between variables. Its interpretation depends on the statistical method, study design, outcome, and biological context. In a genetic association study, an effect size may describe how much a phenotype changes with each additional copy of an allele. In differential gene expression analysis, it may represent the fold change in expression between experimental conditions. In a clinical study, it may describe a difference in a measurement, a relative risk, or an odds ratio. Effect sizes can therefore be expressed in their original measurement units or on standardized or transformed scales.
  • Effect sizes are commonly divided into unstandardized and standardized measures. An unstandardized effect size is expressed in the original units of the measured variable. For example, a difference in gene expression measured in normalized expression units, a change in blood glucose concentration, or a change in body weight can be reported directly. Such measures are often easier to interpret biologically because they retain the original scale. A standardized effect size expresses the magnitude of an effect relative to a measure of variability, such as a standard deviation. Standardized measures are useful when comparing results obtained using different measurement scales, although they may be less intuitive biologically.
  • In studies comparing two groups, the mean difference is a common unstandardized effect size. It is calculated by subtracting the mean of one group from the mean of another group. For example, if the average expression level of a gene is 12 units in a treatment group and 8 units in a control group, the mean difference is 4 units. The sign indicates the direction of the difference according to the order in which the groups are subtracted. Researchers should always state the comparison clearly so that a positive or negative effect can be interpreted correctly.
  • The standardized mean difference expresses the difference between two group means in units of pooled standard deviation. Cohen’s d is a commonly used standardized measure:

[
d = \frac{\bar{x}_1-\bar{x}2}{s{\text{pooled}}}
]

  • where (\bar{x}_1) and (\bar{x}2) are the group means and (s{\text{pooled}}) is the pooled standard deviation. Hedges’ g is a related measure that applies a small-sample correction to reduce bias in the standardized mean difference. These measures are useful in comparing experimental results across studies, but their interpretation depends on the distribution of the data, study design, and variability within groups. Conventional descriptions of small, medium, and large effects are only rough guidelines and should not replace biological interpretation.
  • In regression analysis, an effect size is often represented by a regression coefficient. In linear regression, the coefficient describes the expected change in the outcome associated with a one-unit increase in a predictor, while holding other included predictors constant. For example, in a genetic association model, a regression coefficient may estimate the average change in a quantitative trait for each additional copy of an effect allele. In logistic regression, coefficients are expressed on the log-odds scale. Exponentiating a logistic regression coefficient produces an odds ratio, which describes the multiplicative change in the odds of an outcome associated with a one-unit increase in a predictor.
  • Odds ratios are widely used in GWAS and case-control studies. An odds ratio greater than one indicates higher odds of the outcome for the group or allele being compared, while an odds ratio below one indicates lower odds. An odds ratio of one indicates no association on the odds scale. For example, an odds ratio of 1.25 indicates 25% higher odds, whereas an odds ratio of 0.80 indicates 20% lower odds. However, an odds ratio is not generally equivalent to a relative risk, particularly when the outcome is common. Researchers should avoid describing an odds ratio as a percentage increase or decrease in probability or risk without appropriate qualification.
  • For quantitative traits, genetic association studies commonly report the estimated beta coefficient, its standard error, and a confidence interval. Under an additive genetic model, the beta coefficient usually represents the expected change in the phenotype for each additional copy of the effect allele, assuming the model is correctly specified. For example, a beta coefficient of 0.35 for a blood measurement means that each additional copy of the effect allele is associated with an estimated increase of 0.35 units in that measurement. The interpretation depends on the phenotype scale, allele coding, covariate adjustment, and genetic model. Researchers should report the effect allele and the units of the outcome to make the estimate interpretable.
  • In logistic regression-based genetic association studies, the estimated coefficient is often transformed into an odds ratio. If the estimated log-odds coefficient is (\beta), then:

[
OR = e^\beta
]

  • The standard error of the log-odds coefficient is used to calculate uncertainty on the log scale. The resulting confidence interval can then be exponentiated to obtain a confidence interval for the odds ratio. This transformation is important because odds ratios are positive and their sampling distributions are often more appropriately handled on the logarithmic scale.
  • For differential gene expression analysis, effect sizes are commonly reported as fold changes or log2 fold changes. A fold change describes the ratio of expression between two conditions. A fold change of 2 indicates that expression is twice as high in one condition as in the reference condition, while a fold change of 0.5 indicates half the expression. Log2 fold change is frequently used because it provides a symmetric scale for increases and decreases. A log2 fold change of 1 corresponds to a twofold increase, while a log2 fold change of -1 corresponds to a twofold decrease. A value of zero indicates no change on this scale. Tools such as DESeq2 and edgeR estimate differential expression using statistical models designed for sequencing count data, and their reported effect estimates should be interpreted alongside uncertainty and adjusted p-values.
  • In addition to differences and regression coefficients, bioinformatics studies use several other effect-size measures. Correlation coefficients quantify the strength and direction of association between two variables. Pearson’s correlation coefficient measures linear association, while Spearman’s rank correlation measures monotonic association based on ranks. Values near positive one indicate strong positive association, values near negative one indicate strong negative association, and values near zero indicate little or no association of the type measured. A correlation coefficient does not establish causation and may be affected by outliers, confounding, nonlinear relationships, and restricted ranges.
  • Relative risk and risk difference are frequently used in epidemiological and clinical studies. Relative risk compares the probability of an outcome between two groups, whereas risk difference measures the absolute difference between those probabilities. These measures answer different questions. A relative risk can appear substantial even when the absolute difference is small, especially when the outcome is rare. Therefore, reporting absolute and relative measures together can improve the interpretation of clinical and biological findings.
  • A confidence interval is a range of values calculated from sample data using a statistical procedure. It provides information about the uncertainty and precision of an estimated effect size. A 95% confidence interval is produced by a method that, under its assumptions, would contain the true parameter in approximately 95% of repeated samples. In the conventional frequentist interpretation, the true parameter is fixed, while the interval varies from sample to sample. A 95% confidence interval does not mean that there is a 95% probability that the true parameter lies inside one particular interval. That probability interpretation belongs more naturally to Bayesian credible intervals, which are based on a posterior probability distribution and a specified prior.
  • For many estimates that are approximately normally distributed, a confidence interval can be calculated using the estimate, its standard error, and a critical value from the standard normal distribution. A commonly used approximate 95% confidence interval is:

[
\text{Estimate} \pm 1.96 \times \text{Standard Error}
]

For example, if a regression coefficient is 0.40 and its standard error is 0.10, the approximate 95% confidence interval is:

[
0.40 \pm (1.96 \times 0.10)
]

  • This gives an interval of approximately 0.204 to 0.596. The interval indicates that the estimate is more precise than one with a substantially wider interval, assuming comparable measurement scales and valid statistical assumptions. For smaller samples or models with estimated residual degrees of freedom, a t-distribution critical value may be more appropriate than 1.96.
  • The width of a confidence interval is influenced by sample size, data variability, study design, measurement precision, and the statistical model. Larger sample sizes generally reduce standard errors and produce narrower intervals, provided that the observations provide additional independent information. Greater variability generally increases uncertainty and widens intervals. In genetic studies, the frequency of an allele can also influence the precision of an estimated effect. Rare variants may have fewer observed copies and therefore produce less precise estimates, particularly when sample sizes are limited. Imbalanced case-control sampling, relatedness, population structure, missing data, and inaccurate phenotype measurements can also affect the reliability of estimates and their intervals.
  • Confidence intervals are closely connected to hypothesis testing. For a two-sided test at the 5% significance level, a 95% confidence interval for a parameter will generally exclude the null value when the corresponding test produces a p-value below 0.05, provided that both procedures use compatible assumptions and methods. The null value depends on the effect-size measure. For a mean difference, regression coefficient, or correlation expressed on its usual scale, the null value is generally zero. For an odds ratio or relative risk, the null value is one. This relationship is useful when interpreting statistical results, but it does not mean that confidence intervals and p-values communicate identical information. Confidence intervals show a range of effect sizes compatible with the data and method, while p-values quantify the compatibility of the observed data with a specified null hypothesis.
  • In GWAS, confidence intervals are particularly useful for evaluating the magnitude and precision of genetic associations. A variant may reach genome-wide statistical significance because of a very large sample size, even when its estimated effect on the phenotype is small. Conversely, a variant with a potentially meaningful effect may have a wide confidence interval if the study contains relatively few informative observations. Researchers should therefore consider the effect estimate, confidence interval, allele frequency, sample size, phenotype scale, and replication evidence rather than relying on p-values alone.
  • For binary traits, confidence intervals around odds ratios help determine the range of association magnitudes compatible with the data. If an odds ratio is 1.30 with a 95% confidence interval from 1.15 to 1.47, the interval excludes one and indicates a statistically significant positive association at the conventional two-sided 5% level, assuming the corresponding test and interval are compatible. If the interval ranges from 0.85 to 1.40, it includes one, so the data do not provide sufficient evidence to reject the null hypothesis at that level. However, this does not establish that the effect is absent. The interval may include both negligible and potentially meaningful effects, and its width should be considered when assessing the study’s precision.
  • In transcriptomics, confidence intervals can help characterize uncertainty in estimated fold changes. A gene may have a large estimated expression difference but a wide interval because of limited biological replication or substantial variation among samples. Another gene may have a smaller estimated difference but a narrower interval because the measurements are more consistent. Differential expression analysis should account for the distribution of sequencing counts, library size, biological variability, and multiple testing. Methods such as DESeq2 and edgeR use model-based approaches for count data rather than relying on simple comparisons of raw expression values. The exact uncertainty measures and interval estimates available depend on the software and statistical procedure.
  • In proteomics and metabolomics, effect sizes may represent differences in protein abundance or metabolite concentration between experimental groups. Log-transformed abundance ratios are often used because molecular measurements can be highly skewed and vary over several orders of magnitude. Confidence intervals help describe the uncertainty of these differences and can reveal whether an apparently large effect is estimated precisely. However, technical variation, missing measurements, batch effects, normalization procedures, and differences in detection limits can influence the estimates. Researchers should report the scale of measurement and the transformation used when presenting effect sizes.
  • In machine learning and predictive bioinformatics, effect sizes have a different but related role. Researchers may compare model performance using differences in accuracy, sensitivity, specificity, area under the receiver operating characteristic curve, precision-recall area, or other performance measures. Confidence intervals can quantify uncertainty in these metrics, especially when models are evaluated on finite test datasets. Bootstrap resampling and repeated cross-validation can be used to estimate variability, although the resampling design must respect the data structure. For example, samples from the same individual, family, sequencing batch, or study cohort should not be treated as independent when the evaluation design requires grouping. A confidence interval around predictive performance does not by itself establish that a model will generalize to a new population or clinical setting.
  • Meta-analysis combines effect estimates from multiple studies to obtain an overall estimate. Studies may report mean differences, standardized mean differences, odds ratios, risk ratios, or regression coefficients. In a fixed-effect model, the analysis assumes that all studies estimate a common underlying effect, while a random-effects model allows true effects to vary across studies according to a distribution. Each study’s contribution is commonly weighted according to the inverse of its estimated variance, with additional between-study variance incorporated in a random-effects model. The pooled effect is reported with a confidence interval, and heterogeneity measures such as (I^2) and (\tau^2) help describe variation among study results. A narrow pooled confidence interval should not be interpreted as proof that the result is universally applicable, particularly when studies differ in ancestry, phenotype definition, technology, or study design.
  • Confidence intervals can also be calculated using bootstrap methods. Bootstrapping repeatedly resamples observations from the original dataset, with replacement, and recalculates the effect estimate. The distribution of the resampled estimates can then be used to construct an interval. Bootstrap methods are useful when analytical standard errors are difficult to derive or when the sampling distribution is not well approximated by a normal distribution. However, bootstrap procedures must reflect the actual sampling structure. In clustered or family-based data, resampling individual observations independently may produce misleading intervals; resampling should instead occur at the appropriate cluster or sampling-unit level.
  • In Bayesian analysis, uncertainty is often summarized using credible intervals rather than confidence intervals. A 95% Bayesian credible interval contains 95% of the posterior probability for the parameter under the specified model and prior distribution. This interpretation differs from that of a frequentist confidence interval. Bayesian credible intervals are used in fine-mapping, hierarchical models, gene expression analysis, and other probabilistic approaches. For example, a Bayesian genetic fine-mapping analysis may estimate posterior inclusion probabilities for candidate variants and construct a credible set intended to contain a causal variant with a specified posterior probability under the model. Such conclusions depend on the assumptions, priors, linkage disequilibrium information, and completeness of the variant data.
  • The interpretation of effect sizes and confidence intervals requires attention to several common limitations. First, a statistically significant effect is not necessarily biologically important. A very small effect may be precisely estimated in a large dataset but have limited practical relevance. Second, a wide confidence interval indicates substantial uncertainty and may reflect insufficient information rather than the absence of an association. Third, confidence intervals depend on the statistical model and its assumptions. Model misspecification, unmeasured confounding, population stratification, batch effects, selection bias, and measurement errors can produce misleading estimates even when intervals are narrow. Fourth, confidence intervals calculated for many thousands or millions of features are generally individual, unadjusted intervals unless a simultaneous or multiplicity-adjusted procedure is used. They should not be interpreted as providing family-wise coverage across all tested genes or variants.
  • Effect sizes can also be affected by winner’s curse, particularly in large-scale discovery studies. When results are selected because they exceed a significance threshold, the estimated effects of selected associations tend to be larger than their true underlying effects on average. This is especially relevant for variants with modest effects or low allele frequencies. Independent replication, larger follow-up studies, shrinkage methods, and meta-analysis can help reduce the impact of this bias. Researchers should distinguish discovery-stage estimates from replicated or externally validated effect estimates.
  • The choice of effect-size measure should be guided by the biological question and the study design. A mean difference is suitable when comparing measurements on a common scale, while a standardized mean difference may be useful when combining studies that use different scales for the same underlying construct. Odds ratios are appropriate for many case-control analyses, but absolute risks may be more useful for clinical interpretation. Regression coefficients are useful for continuous traits and adjusted associations, while correlation coefficients describe the strength and direction of relationships. For differential expression, log2 fold changes are commonly used to describe relative expression differences. The selected measure should be reported with its units, reference group, direction, and relevant model assumptions.
  • Python and R provide extensive tools for calculating effect sizes and confidence intervals. The following Python example calculates a mean difference and an approximate confidence interval using the standard error and a normal critical value. It is intended for independent groups with suitable assumptions; for small samples, unequal variances, paired observations, or non-normal data, an appropriate t-based or resampling procedure may be preferable.

import numpy as np

from scipy import stats

group_a = np.array([10.2, 11.1, 9.8, 10.7, 11.4])

group_b = np.array([8.9, 9.2, 8.5, 9.6, 8.8])

mean_a = np.mean(group_a)

mean_b = np.mean(group_b)

effect = mean_a – mean_b

# Welch standard error for the difference in means

se = np.sqrt(

    np.var(group_a, ddof=1) / len(group_a)

    + np.var(group_b, ddof=1) / len(group_b)

)

# Welch-Satterthwaite degrees of freedom

v_a = np.var(group_a, ddof=1) / len(group_a)

v_b = np.var(group_b, ddof=1) / len(group_b)

df = (v_a + v_b) ** 2 / (

    (v_a ** 2 / (len(group_a) – 1))

    + (v_b ** 2 / (len(group_b) – 1))

)

critical_value = stats.t.ppf(0.975, df)

ci_lower = effect – critical_value * se

ci_upper = effect + critical_value * se

print(“Mean difference:”, effect)

print(“95% confidence interval:”, ci_lower, ci_upper)

  • The following Python example calculates an odds ratio and its approximate 95% confidence interval from a two-by-two contingency table. It uses the conventional log-odds-ratio approximation and should be used cautiously when cell counts are small or zero. Exact or penalized methods may be more appropriate in those circumstances.

import numpy as np

# Rows: exposed and unexposed

# Columns: cases and controls

a = 80

b = 120

c = 50

d = 150

odds_ratio = (a * d) / (b * c)

log_or = np.log(odds_ratio)

se_log_or = np.sqrt(

    1 / a + 1 / b + 1 / c + 1 / d

)

lower_log = log_or – 1.96 * se_log_or

upper_log = log_or + 1.96 * se_log_or

ci_lower = np.exp(lower_log)

ci_upper = np.exp(upper_log)

print(“Odds ratio:”, odds_ratio)

print(“95% confidence interval:”, ci_lower, ci_upper)

  • In R, the effectsize package provides functions for calculating several standardized effect sizes, while broom can organize model estimates and confidence intervals into tidy data frames. Base R functions such as t.test() provide confidence intervals for differences in means, and confint() can calculate intervals for supported fitted models. For example:

group_a <- c(10.2, 11.1, 9.8, 10.7, 11.4)

group_b <- c(8.9, 9.2, 8.5, 9.6, 8.8)

# Welch two-sample t-test and confidence interval

result <- t.test(group_a, group_b)

print(resultestimate)print(resultconf.int)

print(result$p.value)

For a logistic regression model, confidence intervals for regression coefficients can be exponentiated to obtain odds-ratio intervals:

# Example binary outcome model

model <- glm(

  case_status ~ genotype + age + sex,

  data = study_data,

  family = binomial()

)

# Coefficient estimates and confidence intervals

estimates <- coef(model)

intervals <- confint(model)

# Convert genotype coefficient and interval to odds-ratio scale

or <- exp(estimates[“genotype”])

or_ci <- exp(intervals[“genotype”, ])

print(or)

print(or_ci)

  • The example assumes that study_data contains the variables shown and that the genotype predictor is coded appropriately. In real genetic association analyses, researchers should also consider genetic model specification, ancestry, relatedness, study design, covariate selection, and appropriate quality-control procedures.
  • For reproducible bioinformatics research, effect sizes and confidence intervals should be reported together with sample sizes, phenotype definitions, measurement units, reference groups, allele coding, statistical models, covariates, and uncertainty-estimation methods. For large-scale analyses, researchers should also state whether confidence intervals are nominal or adjusted for multiple comparisons and explain how missing data, relatedness, population structure, and batch effects were handled. Reporting the effect estimate, confidence interval, and p-value together provides a clearer account of both the magnitude and statistical evidence of an association.
  • Effect sizes and confidence intervals are essential for moving beyond the simple identification of statistically significant results. They help researchers evaluate whether observed differences are substantial, whether estimates are precise, how results compare across studies, and whether findings are likely to be biologically or clinically relevant. In bioinformatics, where datasets often contain millions of measurements and very large sample sizes, careful interpretation of effect magnitude and uncertainty is particularly important. These measures support more transparent statistical reporting, meaningful biological interpretation, reliable replication, and evidence-based conclusions.
Author:

Leave a Reply

Your email address will not be published. Required fields are marked *